Ticker AUPH – Aurinia Pharma – sales, description, marketcap – Tickerday.com

AUPH

Aurinia Pharma

Index: NASDAQ; Sector: ; Industry: ;

Marketcap: 1.68B; Volume: 162.25K; AvgVol 3m: 1.50M; Beta: ;

Cost estimate:

P/E: ; EPS: ; EPS growth quarter/prev quarter: ;

EPS growth this year: -53.00%; EPS growth past 5 years: ;

EPS ttm: -1.37;

P/S: 6042.63; P/B: 7.18; P/Cashflow: ; P/FCF: ;

Sales: 320.00K; Sales growth quarter/prev quarter: 0.00%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: ; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 17.11%; Insider Transactions:0.00%;

Institutional Ownership: 49.68%; Institutional Transactions: ;

Data update: 07/10/2020.

Leave a comment

Your email address will not be published. Required fields are marked *